KATHI VAUGHN: Open Payments
NPI 1700074762 · ALTAMONT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 40 payments from 11 companies in 2025. Trend: 2023 $658 · 2024 $1,125 · 2025 $753
Food & beverage: $714Education: $39
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $218 |
| ABBVIE INC. | 13 | $163 |
| Novo Nordisk Inc | 6 | $110 |
| Lundbeck LLC | 2 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Lilly USA, LLC | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Exact Sciences Corporation | 1 | $22 |
| PFIZER INC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: REXULTI, AIRSUPRA, VRAYLAR, BREZTRI, QULIPTA, Rybelsus, CAPLYTA, MOUNJARO.
Industry payments across IL — which companies pay providers there.
